Fighting AMR for Child Health: Antibiotic Development and Access

In this second deep dive, Glenda Gray examines why the global antibiotic pipeline is failing and how access gaps are fuelling resistance. She discusses GARDP's mission-driven research and development model, the neglect of paediatric antibiotics, and how shortages of first-line treatments drive reliance on last-resort drugs, worsening the antimicrobial resistance crisis.

Timestamps:
00:00 – Introduction

00:58 – Antibiotic development

03:05 – GARDP's model

04:15 – Paediatric antibiotics

04:58 – Antibiotic shortages

05:50 – Access gaps